Structured evidence table for Soluble Fiber Cholesterol Randomized Trial, generated from 1 reusable source document in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Soluble Fiber Cholesterol Randomized Trial | Findings consistently demonstrated that dietary fiber, especially soluble and mixed types, significantly improved insulin resistance as measured by HOMA-IR and related indices. | 1 | Hebbar S (2026) | Impact of dietary fiber intake on insulin resistance in type 2 diabetes: A systematic review. |
| Soluble Fiber Cholesterol Randomized Trial | Despite these challenges, the evidence strongly supports dietary fiber as an effective adjunct in managing insulin resistance in T2DM. | 1 | Hebbar S (2026) | Impact of dietary fiber intake on insulin resistance in type 2 diabetes: A systematic review. |
| Soluble Fiber Cholesterol Randomized Trial | This systematic review examines the impact of dietary fiber intake on insulin resistance in individuals with type 2 diabetes mellitus (T2DM). | 1 | Hebbar S (2026) | Impact of dietary fiber intake on insulin resistance in type 2 diabetes: A systematic review. |
| Soluble Fiber Cholesterol Randomized Trial | Given the global rise in T2DM prevalence and the central role of insulin resistance in its pathophysiology, there is an increasing emphasis on nonpharmacological interventions, such as dietary fiber, to manage glycemic outcomes. | 1 | Hebbar S (2026) | Impact of dietary fiber intake on insulin resistance in type 2 diabetes: A systematic review. |
Source documents